Hanlon Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Sell
2,651
-1,103
-29% -$89K 0.11% 217
2026
Q1
$325K Buy
3,754
+1,427
+61% +$137K 0.18% 169
2025
Q4
$224K Buy
+2,327
New +$226K 0.12% 190

Other funds holding MDT

Hanlon Investment Management's MDT Position: Q2 2026 in Review

Hanlon Investment Management reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $89K and leaving 2,651 shares worth $207K. The position accounts for 0.11% of the portfolio, ranked #217.

Hanlon Investment Management first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $325K in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hanlon Investment Management held 2,651 shares of Medtronic worth $207K as of Q2 2026.
  • Hanlon Investment Management sold 1,103 Medtronic shares in Q2 2026, an estimated $89K.
  • Medtronic made up 0.11% of Hanlon Investment Management's portfolio in Q2 2026, its #217 holding.
  • Hanlon Investment Management first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Hanlon Investment Management's Medtronic position peaked at $325K in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hanlon Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.